Patricia Munch Danzon
Born 1946-01-01
Identifiers
- Open LibraryOL392786A
Top Subjects
- United States (16)
- Medical personnel -- Malpractice -- United States (7)
- Insurance, Physicians' liability -- United States (3)
- Malpractice (3)
- Pharmaceutical policy (3)
- Pharmaceutical industry (3)
- Insurance, Liability (2)
Books by Patricia Munch Danzon
Total count: 30
-
Causes of the medical malpractice insurance "crisis"risks and regulationsRand Corp.1976-01-01
-
A dynamic model for optimum bonus managementRand1977-01-01
-
Costs and benefits of the tort system if viewed as a compensation systemRand Corp.1977-01-01
-
The disposition of medical malpractice claimsRand1980-01-01
-
Civilian earnings of military retireesRand Corporation1980-01-01
-
Why are malpractice premiums so high--or so low?Rand1980-01-01
-
"Profits" in hospital laboratoriesthe effects of reimbursement policies on hospital costs and chargesRand Corp.1980-01-01
Contingent fees for personal injury litigationRand1980-01-01-
Economic factors in the use of laboratory tests by office-based physiciansRand1980-01-01
Economic analysis of medical malpracticethree reports.U.S. Dept. of Health and Human Services, Health Care Financing Administration, Office of Research, Demonstrations, and Statistics1981-01-01-
The resolution of medical malpractice claims, research results and policy implicationsRand1982-01-01
-
The resolution of medical malpractice claims, modeling the bargaining processRand1982-01-01
-
Settlement out of courtthe disposition of medical malpractice claimsRand Corp.1982-01-01
-
The frequency and severity of medical malpractice claimsRand Corporation1982-01-01
Factors affecting laboratory test use and pricesexecutive summaryRand Corporation1983-01-01
Medical malpracticetheory, evidence, and public policyHarvard University Press1985-01-01
New evidence on the frequency and severity of medical malpractice claimsRand, Institute for Civil Justice1986-01-01-
The Effects of tort reforms on the frequency and severity of medical malpractice claimsa summary of research resultsRand1986-01-01
-
Options for health care in New Zealandreport for the New Zealand Business RoundtableNew Zealand Business Roundtable1991-01-01
-
Regulation and pricing of pharmaceuticals in New ZealandNew Zealand Business Roundtable1992-01-01
Global budgets versus competitive cost-control strategiesAEI Press1994-01-01
Pharmaceutical price regulationnational policies versus global interestsAEI Press1997-01-01
Rate regulation of workers' compensation insurancehow price controls increase costsAEI Press1998-01-01-
Pharmaceuticalsaccess, cost, pricing, and directions for the futureCenter for Policy Research, Maxwell School of Citizenship and Public Affairs, Syracuse University2001-01-01
The life cycle of pharmaceuticalsa cross-national perspectiveOffice of Health Economics2002-01-01-
Reference pricing of pharmaceuticals for medicareevidence from Germany, the Netherlands and New ZealandNational Bureau of Economic Research2003-01-01
-
Productivity in pharmaceutical-biotechnology R&Dthe role of experience and alliancesNational Bureau of Economic Research2003-01-01
-
Mergers and acquisitions in the pharmaceutical and biotech industriesNational Bureau of Economic Research2004-01-01
-
Effects of regulation on drug launch and pricing in interdependent marketsNational Bureau of Economic Research2008-01-01
The Oxford handbook of the economics of the biopharmaceutical industryOxford University Press2012-01-01